Pages that link to "Q44858911"

The following pages link to Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination (Q44858911):

Displaying 25 items.

• A recirculatory model of the pulmonary uptake and pharmacokinetics of lidocaine based on analysis of arterial and mixed venous data from dogs (Q32167586) (← links)
• Induction speed is not a determinant of propofol pharmacodynamics (Q34074751) (← links)
• Applications of minimal physiologically-based pharmacokinetic models (Q36517093) (← links)
• Properties of the recirculation model: Calculation of the amount of drug in the body from blood concentration data, with application to absorption rate calculations (Q36658943) (← links)
• A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam (Q36910537) (← links)
• The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II). (Q38730326) (← links)
• Instantaneous input Hypothesis in Pharmacokinetic Studies (Q41530734) (← links)
• Arterial-venous concentration gradient as a potential source of error in pharmacokinetic studies. Plasma concentration differences of 6-chloro-2-pyridylmethyl nitrate on constant infusion to rats (Q42198811) (← links)
• Pharmacokinetic interaction between oltipraz and dimethyl-4,4‘-dimethoxy-5,6,5′,6’-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB) after single intravenous and oral administration to rats (Q44646553) (← links)
• An assessment of methods for sampling blood to characterize rapidly changing blood drug concentrations (Q44698615) (← links)
• [Target-controlled infusion. Clinical relevance and special features when using pharmacokinetic models]. (Q45953760) (← links)
• Determination of the distribution volume that can be used to calculate the intravenous loading dose (Q46633580) (← links)
• A compartmental analysis of the pharmacokinetics of propofol in sheep (Q51410941) (← links)
• A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics. (Q52066921) (← links)
• Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement. (Q52454083) (← links)
• A note on appropriate constraints on the initial input response when applying deconvolution. (Q52630596) (← links)
• Negative power functions of time in pharmacokinetics and their implications. (Q52668377) (← links)
• Wastewater-based epidemiology in low Human Development Index states: bias in consumption monitoring of illicit drugs (Q57137697) (← links)
• Opportunities and Challenges Related to the Implementation of Model-Based Bioequivalence Criteria (Q58094288) (← links)
• Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats (Q58854622) (← links)
• Analysis of drugs and other toxic substances in biological samples for pharmacokinetic studies (Q68631795) (← links)
• Pharmacokinetics of drugs in blood I. Unusual distribution of gentamicin (Q70788234) (← links)
• Modelling of initial distribution of drugs following intravenous bolus injection (Q71684287) (← links)
• Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling? (Q73196837) (← links)
• A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes (Q73848871) (← links)